Sub-categories

Choose categories from the dropdowns below to see different breakdowns of the data. Some will not be available until a higher level is chosen.

Download source data (.csv)

Download source data for disaggregations (.csv)

No headline data available

This table provides metadata for the actual indicator available from Rwanda statistics closest to the corresponding global SDG indicator. Please note that even when the global SDG indicator is fully available from Rwandan statistics, this table should be consulted for information on national methodology and other Rwandan-specific metadata information.

Indicator available

Proportion of the target population covered by all vaccines included in their national programme
Indicator description

This indicator measures the proportion of the target population covered by the following vaccines: (1) 3 doses of diphtheria-tetanus-pertussis (DPT3) vaccine; (2) Measles-containing vaccine second-dose (MCV2); (3) 3rd dose of pneumococcal conjugate (PCV3) vaccine; (4) Final dose of human papillomavirus (HPV) vaccine.
Geographical coverage

Rwanda
Unit of measurement

Percentage (%)
Definitions

The target populations correspond to each vaccine as follows: (1) 12-23 months; (2) 24-35 months; (3) 12-23 months; (4) Girls age 12.
Calculations

(Number of target population vaccinated) / (Total target population) * 100
Other information

The full national vaccination programme for children up to 35 months includes BCG, three doses of DPT-HepB-Hib, four doses of OPV, one dose of IPV, three doses of pneumococcal vaccine, two doses of rotavirus vaccine, and two doses of measles and rubella. A selection is reported here; data on the other vaccines are available at the linked data source.
Comments and limitations

Demographic and Health Survey (DHS) figures on diphtheria-tetanus-pertussis vaccine coverage are available from 2008. Figures on measles-containing vaccine second-dose coverage are available from 2020, although figures on single-dose coverage are available earlier; Rwanda introduced the second dose in 2014 and this was not yet reflected in the DHS 2015. Figures on pneumococcal conjugate vaccine coverage are available from 2015; this vaccine was introduced in 2009 and was not yet reflected in the DHS 2010. Figures on human papillomavirus vaccine coverage are available in 2025 only; due to the lack of comparable timeseries data, this series is not reported here.
Data last updated

27/10/2026
Metadata last updated

27/10/2026

This table provides information on metadata for SDG indicators as defined by the UN Statistical Commission. Complete global metadata is provided by the UN Statistics Division.

Indicator name

Proportion of the target population covered by all vaccines included in their national programme
Indicator number

3.b.1
Target name

Support the research and development of vaccines and medicines for the communicable and non‐communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
Target number

3.b
Global indicator description

Coverage of DTP containing vaccine (3rd dose): Percentage of surviving infants who received the 3rd doses of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year. Coverage of Measles containing vaccine (2nd dose): Percentage of children who received the 2nd dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year. Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the nationally recommended last dose of pneumococcal conjugate vaccine in a given year. Coverage of HPV vaccine (last dose in the schedule): Percentage of 15 years old girls who received the recommended doses of HPV vaccine. Currently performance of the programme in the previous calendar year based on target age group is used.
UN designated tier

Tier I
UN custodian agency

World Health Organization (WHO), United Nations Children’s Fund (UNICEF)
Link to UN metadata United Nations Sustainable Development Goals Metadata (pdf 894 KB) opens in a new window

Source 1

Organisation

National Institute of Statistics of Rwanda (NISR)
Periodicity

Every 5 years
Earliest available data

1992
Geographical coverage

Rwanda
Link to data source Demographic and Health Survey (DHS) opens in a new window
Release date 2025
Next release

2030
Statistical classification

Official statistics
Contact details

info@statistics.gov.rw
Other information

Figures on diphtheria-tetanus-pertussis vaccine coverage are available from 2008. Figures on measles-containing vaccine second-dose coverage are available from 2020, although figures on single-dose coverage are available earlier. Figures on pneumococcal conjugate vaccine coverage are available from 2015. Figures on human papillomavirus vaccine coverage are available in 2025 only.
Back to top